Detailed Coverage

Radico Khaitan Q1 FY27 Profits Surge 76% to ₹229.6 Crore

Consolidated Net Profit: ₹229.60 Crore
Consolidated Revenue: ₹5,867.69 Crore

Reader Takeaway: Strong profit growth driven by revenue expansion, though joint venture reporting requires attention.

What just happened

Radico Khaitan Limited announced its financial results for the first quarter of the fiscal year 2027 (ended June 30, 2026). The company posted a significant year-on-year increase in both consolidated and standalone net profits. Consolidated revenue also saw an uptick.

Why this matters

The strong profit growth indicates improved operational efficiency and market performance for Radico Khaitan. The rise in revenue suggests sustained demand for its products. This positive financial showing is a key indicator for investors evaluating the company's current health and future prospects.

The backstory

Radico Khaitan is a prominent player in the Indian alcoholic beverages industry. The company has been focused on expanding its product portfolio and market reach. This quarter's performance builds on its ongoing efforts to drive profitability.

What changes now

With a strong start to the fiscal year, investors will be looking for Radico Khaitan to maintain this growth momentum throughout FY27. The approved financial results, backed by an unmodified auditor report, provide a clear picture of the company's performance.

Risks to watch

A watch point highlighted is the inclusion of unreviewed financial information from two joint ventures in the consolidated results. While a small portion, investors should note that this part of the consolidated performance relies on management-furnished interim financial data.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

• Consolidated Revenue (Q1 FY27): ₹5,867.69 crore (up from ₹5,313.52 crore in Q1 FY26).
• Consolidated Net Profit (Q1 FY27): ₹229.60 crore (up from ₹130.52 crore in Q1 FY26).
• Standalone Net Profit (Q1 FY27): ₹226.01 crore (up from ₹133.34 crore in Q1 FY26).
• Equity Shares Allotted: 33,417 on exercise of ESOPs.
• New Stock Options Granted: 60,000 at ₹2,838.07 per share.
• Board Approval Date: July 28, 2026.

What to track next

Investors will be keen to observe if Radico Khaitan can sustain this robust profit growth in subsequent quarters and how the performance of its joint ventures evolves.